The Role of Lipopolysaccharide Structure in Monocyte Activation and Cytokine Secretion
Overview
Affiliations
Background: The lipopolysaccharide (LPS) molecule is composed of a hydrophobic lipid region (Lipid A), an oligosaccharide core, and an O-Antigen chain. Lipid A has been described as the molecular region responsible for inducing activation of immune cells. We hypothesize that the O-Antigen plays a critical role in the activation and responsiveness of mononuclear cell immune function.
Methods: Peripheral blood mononuclear cells (PBMCs) from healthy volunteers were stimulated with LPS, LPS with attenuated O-Antigen (RF5), or Lipid A (DPL), which lacks an O-Antigen. Selected cells were pretreated with a blocking antibody to CD14. Western blots were performed to determine activation of mitogen-activated protein kinases (MAPK) p38, ERK, and JNK at selected time-points. RNA was extracted for RT-PCR quantification of TNF-α and IL-10 gene transcription. Supernatants were harvested and analyzed by ELISA for tumor necrosis factor alpha (TNF-α) and interleukin 10 (IL-10).
Results: LPS elicited maximal response, including phosphorylation of p38, ERK, and JNK, synthesis of TNF-α and IL-10 mRNA, and secretion of TNF-α and IL-10. Stimulation with RF5 activated the same pathways to a lesser degree. DPL led to increased phosphorylation of p38 and ERK and increased secretion of IL-10. CD14 blockade was associated with a significant decrease in cytokine secretion by LPS, and abolished cytokine secretion in cells stimulated with RF5 or DPL.
Conclusions: Structural variants of LPS activate monocytes differentially. The complete O-Antigen is important for maximal activation of MAPK, cytokine synthesis, and cytokine secretion. LPS with attenuated O-Antigen and Lipid A activate only certain components of these pathways. LPS with a complete O-Antigen stimulates cytokine secretion that is partially independent of CD14, but shortening or removal of the O-Antigen inhibits this secretion.
Youssry S, Ghoneim H, Barakat R, ElAlfy E Sci Rep. 2025; 15(1):5676.
PMID: 39955339 PMC: 11830086. DOI: 10.1038/s41598-025-88719-5.
Molecular Mechanism of VSV-Vectored ASFV Vaccine Activating Immune Response in DCs.
Ma Y, Shao J, Liu W, Gao S, Zhou G, Qi X Vet Sci. 2025; 12(1).
PMID: 39852910 PMC: 11769090. DOI: 10.3390/vetsci12010036.
Exercise to Prevent Accelerated Vascular Aging in People Living With HIV.
Jones R, Robinson A, Beach L, Lindsey M, Kirabo A, Hinton Jr A Circ Res. 2024; 134(11):1607-1635.
PMID: 38781293 PMC: 11126195. DOI: 10.1161/CIRCRESAHA.124.323975.
Mikkelsen K, Dargahi N, Fraser S, Apostolopoulos V Biomedicines. 2023; 11(9).
PMID: 37761018 PMC: 10526783. DOI: 10.3390/biomedicines11092578.
Linkova N, Khavinson V, Diatlova A, Petukhov M, Vladimirova E, Sukhareva M Int J Mol Sci. 2023; 24(17).
PMID: 37686182 PMC: 10488166. DOI: 10.3390/ijms241713377.